Chaudhary Pradeep D, Rastogi Sanjay, Gupta Prashant, Niranjanaprasad Indra B, Thomas Roy, Choudhury Rupshikha
Professor, Department of Conservative and Endodontics, Bhartiya Vidyapeeth Dental College, Pune, Maharashtra, India.
Reader, Department of Oral and Maxillofacial Surgery, Institute of Dental Science - Bareilly, Uttar Pradesh, India.
J Oral Biol Craniofac Res. 2015 Jan-Apr;5(1):21-7. doi: 10.1016/j.jobcr.2015.02.001. Epub 2015 Mar 5.
To evaluate the preventative effect of intravenous 4 mg of dexamethasone and 8 mg oral dexamethasone on post-operative pain, swelling and trismus after the surgical extraction of mandibular third molars.
A randomized clinical trial comprised of 200 patients (control group I intravenous and experimental group II orally) with impacted lower third molars, average age 20.8 years with no local or systemic problems, with bilateral impacted lower third molars, were operated under local anesthesia. Group I was given 4 mg IV and group II was given 8 mg orally of dexamethasone 1 h before procedure. The choice of which side to operate first and the amount of concentration of medication to use was made randomly and double-blindly. Post-operative pain was evaluated using a visual analog scale (VAS) and the degree of swelling was evaluated through facial reference points' variation. The presence of trismus was analyzed through measurement of the interincisal distance (IID). These assessments were obtained before the operation and 24 h, 48 h and 7th POD.
No significant difference was found in facial swelling and trismus between IV 4 mg injection and oral 8 mg consumption after lower third molar surgery (student t test P > 0.05). The visual analogue scale scores for pain assessment showed no significant difference between IV injection and oral route of dexamethasone (student t test P > 0.05).
Patients can be administered 8 mg oral dexamethasone is as effective as 4 mg intra venous route without much difference in final outcome at any given point of time.
评估静脉注射4毫克地塞米松和口服8毫克地塞米松对下颌第三磨牙拔除术后疼痛、肿胀和牙关紧闭的预防效果。
一项随机临床试验,纳入200例平均年龄20.8岁、无局部或全身问题、双侧下颌第三磨牙阻生的患者(对照组I静脉注射,实验组II口服),在局部麻醉下进行手术。I组在手术前1小时静脉注射4毫克,II组口服8毫克地塞米松。手术先操作哪一侧以及用药浓度随机双盲选择。术后疼痛采用视觉模拟评分法(VAS)评估,肿胀程度通过面部参考点的变化评估。通过测量切牙间距离(IID)分析牙关紧闭情况。这些评估在手术前、术后24小时、48小时和术后第7天进行。
下颌第三磨牙手术后,静脉注射4毫克与口服8毫克地塞米松在面部肿胀和牙关紧闭方面无显著差异(学生t检验P>0.05)。疼痛评估的视觉模拟量表评分显示,地塞米松静脉注射和口服途径之间无显著差异(学生t检验P>0.05)。
患者口服8毫克地塞米松与静脉注射4毫克效果相同,在任何给定时间点最终结果差异不大。